These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19788509)

  • 1. Pressure-aided transfusion of platelets: does it affect the platelets?
    Fischer-Nielsen A; Stissing T; Maansson C; Joergensen BG
    Transfusion; 2010 Feb; 50(2):361-5. PubMed ID: 19788509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation.
    Vetlesen A; Holme PA; Lyberg T; Kjeldsen-Kragh J
    Transfusion; 2012 Jun; 52(6):1321-32. PubMed ID: 22084943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of the hemostatic potential of platelets during storage as evaluated by flow cytometry, thrombin generation, and thrombelastography under conditions promoting formation of coated platelets.
    Svendsen MS; Rojkjaer R; Kristensen AT; Salado-Jimena JA; Kjalke M; Johansson PI
    Transfusion; 2007 Nov; 47(11):2057-65. PubMed ID: 17958535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
    Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
    Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor platelets stored for at least 3 days can elicit activation marker expression by the recipient's blood mononuclear cells: an in vitro study.
    Cognasse F; Hamzeh-Cognasse H; Lafarge S; Acquart S; Chavarin P; Courbil R; Fabrigli P; Garraud O
    Transfusion; 2009 Jan; 49(1):91-8. PubMed ID: 18954408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
    Charania R; Smith J; Vesely SK; Dale GL; Holter J
    Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and product factors affecting platelet transfusion results.
    Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A
    Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viability and function of 8-day-stored apheresis platelets.
    Slichter SJ; Bolgiano D; Jones MK; Christoffel T; Corson J; Rose L; Foley J; Popovsky M; Baril LL; Corda T; Dincecco DM; Snyder EL
    Transfusion; 2006 Oct; 46(10):1763-9. PubMed ID: 17002633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro testing of fresh and lyophilized reconstituted human and baboon platelets.
    Valeri CR; Macgregor H; Barnard MR; Summaria L; Michelson AD; Ragno G
    Transfusion; 2004 Oct; 44(10):1505-12. PubMed ID: 15383025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of platelets in apheresis platelet concentrates and in patient blood after transfusion as assessed by Impact-R.
    Horvath M; Eichelberger B; Koren D; Böhm A; Ay C; Jilma B; Panzer S; Jilma-Stohlawetz P
    Transfusion; 2010 May; 50(5):1036-42. PubMed ID: 20051058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activation and residual activation potential during storage of hyperconcentrated platelet products in two different platelet additive solutions.
    Vetlesen A; Mirlashari MR; Torsheim IA; Kjeldsen-Kragh J
    Transfusion; 2005 Aug; 45(8):1349-55. PubMed ID: 16078925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperatively salvaged red blood cells contain nearly no functionally active platelets, but exhibit formation of microparticles: results of a pilot study in orthopedic patients.
    Oswald E; Streif W; Hermann M; Hengster P; Mittermayr M; Innerhofer P
    Transfusion; 2010 Feb; 50(2):400-6. PubMed ID: 19804574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
    Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
    Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function under high-shear conditions from platelet concentrates.
    Jilma-Stohlawetz P; Horvath M; Eichelberger B; Koren D; Jilma B; Panzer S
    Transfusion; 2008 Jan; 48(1):129-35. PubMed ID: 17894788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension.
    Valeri CR; Macgregor H; Ragno G
    Transfusion; 2005 Apr; 45(4):596-603. PubMed ID: 15819682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters.
    Dijkstra-Tiekstra MJ; Pietersz RN; Huijgens PC
    Vox Sang; 2004 Nov; 87(4):257-63. PubMed ID: 15585021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apheresis donors and platelet function: inherent platelet responsiveness influences platelet quality.
    Garner SF; Jones CI; Stephens J; Burns P; Walton J; Bernard A; Angenent W; Ouwehand WH; Goodall AH;
    Transfusion; 2008 Apr; 48(4):673-80. PubMed ID: 18194381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring survival and function of transfused platelets in Bernard-Soulier syndrome by flow cytometry and a cone and plate(let) analyzer (Impact-R).
    Panzer S; Eichelberger B; Koren D; Kaufmann K; Male C
    Transfusion; 2007 Jan; 47(1):103-6. PubMed ID: 17207237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.